Randomized study of single early instillation of (2″R)-4′-O-tetrahydropyranyl-doxorubicin for a single superficial bladder carcinoma

Cancer

Volumn 94, Issue 9, 2002, Pages 2363-2368

  Okamura, Kikuo ^a   Ono, Yoshinari ^b   Kinukawa, Tsunero ^c   Matsuura, Osamu ^d   Yamada, Shin ^e   Ando, Tadashi ^f   Fukatsu, Toshiaki ^g   Ohno, Yoshiyuki ^b   Ohshima, Shinichi ^b  

^a CHUBU NATIONAL HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c CHUKYO HOSPITAL   (Japan)

^d Komaki Shimin Hospital   (Japan)

^e Okazaki City Hospital   (Japan)

^f Kasugai Municipal Hospital   (Japan)

^g Nagoya Ekisaikai Hospital   (Japan)

Author keywords

(2 R) 4 O tetrahydropyranyl doxorubicin (THP); Chemotherapeutic agent; Prophylactic treatment; Superficial bladder carcinoma

Indexed keywords

PIRARUBICIN;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLOOD TOXICITY; CANCER RECURRENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSURIA; HEMATURIA; HUMAN; MAJOR CLINICAL STUDY; NEPHROTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUPERFICIAL CANCER; TRANSURETHRAL RESECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; URINARY BLADDER NEOPLASMS;

EID: 0036569533     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10496     Document Type: Article

References (16)

1. An overview of intravesical therapy for superficial bladder tumors
2. A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder
3. Long-term follow-up of an EORTC randomized prospective trial comparing intravesical, bacille Calmette-Guerin-RIVM and mitomycin C in superficial bladder cancer
4. Treatment of superficial bladder tumors: Achievements and needs
5. Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: Report from the British Medical Research Council subgroup on superficial bladder cancer (Urological Cancer Working Party)
6. A prospective European organization for research and treatment of cancer genitourinary group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder
7. The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: A further report with 7 years of followup
8. Rapid uptake by cultured tumor cells and intracellular behavior of 4′-O-tetrahydropyranyladriamycin
9. Comparative investigation on use of (2″R)-4′-O-tetrahydropyranyl-adriamycin and adriamycin as intravesical chemotherapy for superficial bladder tumors
10. The absorption of pirarubicin instilled intravesicaly immediately after transurethral resection of superficial bladder cancer
11. Randomized study of single early instillation of (2″R)-4′-O-tetrahydropyranyl-Adriamycin (THP) for a single superficial bladder cancer: An interim report
12. Single-dose versus multiple instillations of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pT1 transitional-cell bladder tumours: Prospective, randomized controlled study
13. Transurethral resection with perioperative instillation of interferon-a or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer: A prospective randomized multicenter study-Finnbladder III
14. Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: Short and long-term followup
15. Influence of thiotepa and doxorubicin instillation at time of transurethral surgical treatment of bladder cancer on tumor recurrence: A prospective, randomized double-blind, controlled trial
16. Long-term fate of 90 patients with superficial bladder cancer randomly assigned to receive or not to receive thiotepa